Fetal Lung Malformations

The following data represents evaluations, procedures and outcomes from the Fetal Center's inception through the end of 2022.


All Patients evaluated for Congenital Lung Malformation (CLM)

  • 28 - 2022
  • 375 - Total

Patients evaluated for high risk CLM*

  • 6 - 2022
  • 83 - Total

Survival to discharge for low risk CLM**

  • 99%

Survival to discharge for high risk CLM

  • 85%

Open fetal surgeries for CLM

  • 0 - 2022
  • 4 - Total

Survival to discharge for open fetal surgeries for CLM

  • 75%

EXIT to resection for CLM

  • 0 - 2022
  • 21 - Total

Survival to discharge for EXIT to resection procedures

  • 95%

*Defined as those with hydrops or CLM volume ratios ≥ 1.6
**Two deaths due to non-pulmonary-related problems